Skip to main content
PMC home page
Springer logoLink to Springer
. 2017 Aug 22;27(3):202–219. doi: 10.1007/s11065-017-9356-2

Imaging Markers of Post-Stroke Depression and Apathy: a Systematic Review and Meta-Analysis

Elles Douven 1, Sebastian Köhler 1, Maria M F Rodriguez 2, Julie Staals 3, Frans R J Verhey 1, Pauline Aalten 1,✉
PMCID: PMC5613051  PMID: 28831649

Abstract

Several brain imaging markers have been studied in the development of post-stroke depression (PSD) and post-stroke apathy (PSA), but inconsistent associations have been reported. This systematic review and meta-analysis aims to provide a comprehensive and up-to-date evaluation of imaging markers associated with PSD and PSA. Databases (Medline, Embase, PsycINFO, CINAHL, and Cochrane Database of Systematic Reviews) were searched from inception to July 21, 2016. Observational studies describing imaging markers of PSD and PSA were included. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to examine the association between PSD or PSA and stroke lesion laterality, type, and location, also stratified by study phase (acute, post-acute, chronic). Other imaging markers were reviewed qualitatively. The search retrieved 4502 studies, of which 149 studies were included in the review and 86 studies in the meta-analyses. PSD in the post-acute stroke phase was significantly associated with frontal (OR 1.72, 95% CI 1.34–2.19) and basal ganglia lesions (OR 2.25, 95% CI 1.33–3.84). Hemorrhagic stroke related to higher odds for PSA in the acute phase (OR 2.58, 95% CI 1.18–5.65), whereas ischemic stroke related to higher odds for PSA in the post-acute phase (OR 0.20, 95% CI 0.06–0.69). Frequency of PSD and PSA is modestly associated with stroke type and location and is dependent on stroke phase. These findings have to be taken into consideration for stroke rehabilitation programs, as this could prevent stroke patients from developing PSD and PSA, resulting in better clinical outcome.

Electronic supplementary material

The online version of this article (doi:10.1007/s11065-017-9356-2) contains supplementary material, which is available to authorized users.

Keywords: Stroke, Depression, Apathy, Imaging, Systematic review, Meta-analysis

Introduction

Post-stroke depression (PSD) and post-stroke apathy (PSA) are frequent neuropsychiatric symptoms after stroke, with estimated prevalence rates between 30 and 40%, respectively, in the first few months after stroke (Hackett et al. 2014). Depression can be defined as a feeling of low mood, loss of interest, and lack of pleasure that persists for a time period of at least 2 weeks (Hackett et al. 2005). Apathy is generally defined as a disorder of diminished motivation, characterized by loss of interest, diminished emotional response, and loss of initiative (Marin 1990), and can occur independently (Levy et al. 1998), or in combination with symptoms of depression (Marin et al. 1993).

According to a previous meta-analysis, approximately 40% of patients with PSA also suffer from PSD (van Dalen et al. 2013). Because depression and apathy share several features, mainly loss of interest, patients with apathy after stroke are frequently misdiagnosed as having PSD (Hama et al. 2011). However, despite the considerable overlap in symptoms between PSD and PSA, there is evidence indicating that the two syndromes seem to develop from different anatomical and neurobiological constructs (Andersson et al. 1999; Hama et al. 2007b, 2016; Hollocks et al. 2015; Murakami et al. 2013).

Earlier studies have already attempted to disentangle the relationship between PSD and PSA, which have shown inconclusive results. The Sydney Stroke Study showed evidence for independence of PSA and PSD when measuring 3 to 6 months post-stroke (Brodaty et al. 2005). However, at 1-year follow-up, a significant overlap between apathy and depression was found (Withall et al. 2011). Contrastingly, Caeiro et al. (2013b) did not find an association between PSA and PSD at 1-year post-stroke. It is important to disentangle the relationship between PSA and PSD, at least from a clinical perspective, since the two syndromes seem to benefit from different types of medication (Withall et al. 2011). Both PSD and PSA are known to have a negative influence on clinical outcome (Hama et al. 2007a; Pohjasvaara et al. 2001) and quality of life (Carod-Artal et al. 2000; Mayo et al. 2009). Early treatment and prevention of PSD and PSA might have a positive effect on functional outcome, thereby limiting the impact of stroke on patients’ daily lives (Ramasubbu and Kennedy 1994). Identification of associated risk factors is thus important for early detection and tailoring of rehabilitation programs.

Several brain imaging markers have been studied in the development of PSD. Early studies suggested that PSD is frequent in patients with left frontal lesions (Brodaty et al. 2005; Hama et al. 2007b), but this hypothesis could not be supported by later studies (Carson et al. 2000). Previous systematic reviews primarily looked at the relationship with lesion laterality, while other potential imaging markers such as lesion location, lesion type, lesion volume, white matter hyperintensities (WMH), and atrophy have been ignored (Carson et al. 2000; Kutlubaev and Hackett 2014; Wei et al. 2015). In addition, imaging markers of PSA have been studied less frequently compared with PSD. Some studies provided evidence that PSA is associated with right hemispheric and subcortical lesions (Andersson et al. 1999; Caeiro et al. 2012; Starkstein et al. 1993), though two recent systematic reviews on lesion location in PSA reported inconclusive results (Caeiro et al. 2013a; van Dalen et al. 2013). Caeiro et al. (2013a) only studied the association with lesion laterality and were not able to find an association, whereas van Dalen et al. provided a qualitative overview of associations with lesion location and laterality, but no meta-analysis, and concluded that no clear association with lesion side or location could be found, though associations with the basal ganglia were most consistent.

A systematic review and meta-analysis was performed to evaluate the association between different brain imaging markers and PSD and PSA, thereby updating and extending previous meta-analyses just focusing on lesion location in association with PSD and PSA. The main aim of the present study was to investigate differences and similarities in several brain correlates associated with PSD and PSA.

Methods

Search Strategy and Selection Criteria

This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Liberati et al. 2009) and by use of a predefined research protocol. Databases (Medline, Embase, PsycINFO, CINAHL, and Cochrane Database of Systematic Reviews) were searched from inception to December 2015 and updated to July 21, 2016. A full description of the search strategy is presented in supplementary Online Resource 1. To be eligible for inclusion, studies had to a) include patients with ischemic or hemorrhagic stroke, b) assess the presence of depressive or apathetic symptoms, c) examine the association between these symptoms and an imaging marker, d) the population had to be human adults, e) sample size had to be larger than 25 to avoid inclusion of spurious associations from underpowered studies, and f) language had to be English, German, Dutch, or French. Studies were excluded if (a) the study population was other than stroke or a combined population was studied without separate results available for stroke, (b) the population consisted of only patients with cognitive impairment or dementia in which vascular damage (infarcts, WMH, atrophy) was studied, or (c) no imaging data or lesion-related data (e.g. lesion location, type, laterality, WMH) were described. Records of research protocols, reviews, and abstracts from scientific meetings were excluded. If studies presented results from the same cohort on a certain outcome measure, data from the study that used the largest group of patients were used, or if they used an equal number of patients, data from the earliest publication were used.

Two reviewers (E.D. and P.A.) independently screened titles and abstracts manually for potential eligibility. Doubtful records were discussed (E.D. and P.A.) and an independent third reviewer (S.K.) decided if doubtful cases were included or not for full-text scrutiny. For completeness, reference lists were screened for additional articles. One reviewer (E.D.) assessed eligibility for inclusion based on full-text screening.

Data Collection and Extraction

Data extraction was performed on selected articles for which full texts were obtained. Two independent reviewers (E.D. and M.R.) extracted data from each study according to a predefined data extraction form. The following information was extracted for each study included in the review: (1) first author and year of publication, (2) demographic characteristics, (3) in- and exclusion criteria if specified, (4) imaging method and imaging markers, (5) questionnaires and criteria used to define PSD or PSA, (6) time of measurement after stroke, (7) statistical methods used and results needed for the meta-analysis, (8) main conclusion and limitations.

Statistical Analyses and Study Quality

Statistical analyses were performed using STATA 13.1 (StataCorp, TX, USA). Statistical significance was defined by p < .05 in two-sided tests. Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated to examine the association between PSD or PSA and stroke lesion laterality, type, and location, also stratified by study phase (acute, post-acute, chronic), using a DerSimonian-Laird random-effects model to account for within- and between-study variance (DerSimonian and Laird 1986). A full description of the observations used in the meta-analyses is presented in supplementary Online Resource 2. Studies were stratified according to phase in which they measured depression or apathy after stroke: acute (< 15 days from stroke onset), post-acute (15 days–6 months), and chronic phase (> 6 months). This stratification was based on the meta-analysis by Caeiro et al. (2013a) and was chosen because the acute stroke phase corresponds with the period of hospitalization and acute care (Buisman et al. 2015) and in this period the risk of complications and recurrent stroke is highest (Prasad et al. 2011). After this period of acute care, patients usually start with rehabilitation and most recovery will take place in the first 6 months (Aziz 2010). Therefore, we defined this period as the post-acute period, and > 6 months as the chronic stroke phase.

To identify possible sources of heterogeneity, random-effect meta-regression models were conducted including the following covariates: study phase, mean age, PSD/PSA prevalence, percentage of females, imaging method (CT/MRI vs. MRI), patient source, and first-ever stroke (yes/no).

The study quality was assessed by a single investigator (E.D.) with the Newcastle-Ottowa Scale (NOS) for case-control and cohort studies, and a modified NOS was applied for cross-sectional studies (Wells et al. 2000). A maximum score of 9 can be obtained and studies with a score < 5 were not included in the meta-analyses (see supplementary Online Resource 3). Visual inspection of asymmetry in funnel plots, in which the relation between sample size and effect size is assessed, was used to test for possible publication bias. Egger’s regression tests were performed to test for significant asymmetry of funnel plots as a test for small-study effects (Egger et al. 1997).

Results

Of 4502 identified articles, 167 articles were selected for full-text screening (see Fig. 1). Nine articles could not be retrieved from authors after several contact requests. Based on full-text evaluation of the remaining articles, 135 articles met inclusion criteria. Reasons for exclusion were: conference abstract (Akiashvili et al. 2013), research protocol (Toso et al. 2004), review article (Beckson and Cummings 1991; Robinson and Starkstein 1989), small sample size (Beblo et al. 1999; Grasso et al. 1994; Lassalle-Lagadec et al. 2012, 2013; Matsuoka et al. 2015; Mayberg et al. 1988; Paradiso et al. 2013; Ramasubbu et al. 1999), other outcome than depression or apathy (Astrom 1996; Downhill and Robinson 1994; Vataja et al. 2005), study population other than stroke or no separate results available for stroke subpopulation (Bella et al. 2010; Grool et al. 2013; O’Brien et al. 2006; Ojagbemi et al. 2013; Sachdev et al. 2007; Tanislav et al. 2015; Wu et al. 2014), and no evaluation of imaging markers (Eriksen et al. 2016). Fourteen additional studies found in reference lists and fulfilling eligibility criteria were included, resulting in a total of 149 studies.

Fig. 1.

Fig. 1

Open in a new tab

Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flowchart of study selection and review. PSA post-stroke apathy, PSD post-stroke depression

Characteristics of Included Studies

A detailed overview of study characteristics for PSD studies (n = 132) and PSA studies (n = 23) is presented in supplementary Online Resource 4 and 5. Of all PSD studies, 51 (39%) studies included only first-ever strokes. Thirty-nine cohorts (30%) were followed prospectively. Some studies used semi-structured psychiatric interviews like the Mini International Neuropsychiatric Interview (Sheehan et al. 1998), or the Structured Clinical Interview for DSM disorders (Spitzer et al. 1995), based on Diagnostic and Statistical Manual of Mental Disorders (DSM) version III (American Psychiatric Asociation 1980) or IV (American Psychiatric Asociation 1994), whereas others used clinician-rated or self-rated questionnaires (e.g. the Hamilton Depression Rating Scale (Hamilton 1960), Montgomery-Åsberg Depression Rating Scale (Montgomery and Asberg 1979), or the Geriatric Depression Scale (Yesavage et al. 1983) to evaluate the presence of PSD, and different cut-offs were applied.

Based on 107 (81%) studies that reported on PSD prevalence within the first year, a median prevalence of 30.4% was found (IQR 20.1–40.0). Of all PSA studies, nine (39%) studies included first-ever stroke patients. Four (17%) cohorts were studied prospectively. Most studies used the Apathy Scale (Starkstein et al. 1992) or Apathy Evaluation Scale (Marin et al. 1991) to evaluate the presence of PSA, and different cut-offs were applied. Based on 20 (87%) studies that reported on PSA prevalence within the first year, a median prevalence of 37.3% was found (IQR 22.1–42.5).

Lesion Laterality

Sixty (45%) studies presented data on PSD and lesion laterality. In the pooled analyses, no significant overall association between PSD and lesion side was found (Table 1). A subgroup analysis stratified by study phase showed a 26% higher odds of PSD after left-sided stroke in the acute phase, but this effect was not statistically significant (OR 1.26, 95% CI 0.95–1.67, I 2 = 60.1%, see Fig. 2). Neither in the post-acute stroke phase (OR 1.00, 95% CI 0.83–1.20, I 2 = 50.4%), nor in the chronic stroke phase (OR 1.12, CI 0.87–1.45, I 2 = 0.0%) a significant association was found with lesion side (see Fig. 3).

Table 1.

Overall effect sizes and Egger’s bias coefficients

Marker Number of studies included Effect size Heterogeneity Publication bias
Odd’s ratio 95% CI I 2 (%) p-value Egger’s bias coefficient p-value
PSD
 Laterality 60a 1.07 0.93–1.23 49.6 < .001 0.14 .743
 Type 14b 0.94 0.65–1.36 33.3 .102 −0.06 .943
 Frontal lesions 30c 1.54 1.27–1.88 43.4 .004 0.92 .132
 Subcortical lesions 10d 1.06 0.81–1.38 0.0 .601 1.00 .186
 Basal ganglia lesions 12e 1.78 1.20–2.66 65.3 .001 0.24 .884
PSA
 Laterality 9 1.16 0.62–2.18 63.5 .005 1.69 .262
 Type 4 0.82 0.19–3.53 75.2 .007 −3.92 .273
 Frontal lesions 5 0.84 0.44–1.59 0.0 .635 2.71 .055
 Subcortical lesions 2 1.03 0.38–2.80 0.0 .686 Not enough data
 Basal ganglia lesions 4 1.32 0.79–2.21 0.0 .891 −0.42 .536
Open in a new tab

CI confidence interval, PSA post-stroke apathy, PSD post-stroke depression

aSix of the 60 studies provided data on more than one time point

bOne of the 14 studies provided data on more than one time point

cFive of the 30 studies provided data on more than one time point

dTwo of the 10 studies provided data on more than one time point

eOne of the 12 studies provided data on more than one time point

Fig. 2.

Fig. 2

Open in a new tab

Forest plot of the relationship between post-stroke depression and lesion laterality. Subanalyses on acute stroke phase are presented. CI confidence interval, OR odds ratio

Fig. 3.

Fig. 3

Open in a new tab

Forest plot of the relationship between post-stroke depression and lesion laterality. Subanalyses on post-acute stroke phase (upper panels) and chronic stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Nine (39%) studies presented data on PSA and lesion laterality. In the pooled analyses, the overall odds of PSA were a bit higher after left-sided stroke (Table 1). A subgroup analysis stratified by study phase showed higher odds after left-sided stroke in the post-acute phase, although this effect was not statistically significant (OR 1.90, 95% CI 0.88–4.09, I 2 = 0.0%, see Fig. 4a). No significant association was found in the acute stroke phase (OR 0.95, 95% CI 0.42–2.16, I 2 = 72.0%, see Fig. 4a) and no studies reported on the association in the chronic phase.

Fig. 4.

Fig. 4

Open in a new tab

Forest plot of the relationship between post-stroke apathy and lesion laterality/type. In panel a, the results of the meta-analysis on lesion laterality are presented. In panel b, the results of the meta-analysis on lesion type are presented. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels) and post-acute stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Lesion Type

Fourteen (11%) studies reported outcomes on lesion type associated with PSD. Overall, no significant association between PSD and lesion type was observed (Table 1). A subgroup analysis by study phase showed no significant association between lesion type and PSD in the acute (OR 0.95, 95% CI 0.59–1.53, I 2 = 14.0%), post-acute (OR 0.94, 95% CI 0.47–1.87, I 2 = 59.9%), or chronic stroke phase (OR 0.76, 95% CI 0.22–2.65, I 2 = 0.0%, see Fig. 5).

Fig. 5.

Fig. 5

Open in a new tab

Forest plot of the relationship between post-stroke depression and lesion type. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels), post-acute stroke phase (middle panels), and chronic stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Four (17%) studies reported outcomes on lesion type associated with PSA. Overall, the odds of PSA after hemorrhagic stroke was not higher than after ischemic stroke (Table 1). A subgroup analysis by study phase showed higher odds after hemorrhagic stroke in the acute phase (OR 2.58, 95% CI 1.18–5.65, I 2 = 0.0%, see Fig. 4b), whereas higher odds after ischemic stroke were found in the post-acute phase (OR 0.20, 95% CI 0.06–0.69, I 2 = 0.0%, see Fig. 4b). Only two studies were included per phase.

Lesion Location

In Table 2, an overview is provided of lesion locations that were significantly associated with PSD. As frontal/anterior, subcortical, and basal ganglia lesions were frequently associated with PSD, meta-analyses were performed on these locations. Thirty (23%) studies reported outcomes on frontal lesion location associated with PSD. Overall, a 54% higher odds of PSD after frontal stroke was found (Table 1). Subgroup analysis suggested this association was limited to PSD in the post-acute stroke phase (OR 1.72, 95% CI 1.34–2.19, I 2 = 47.2%), as no significant association was found in the acute stroke phase (OR 1.21, 95% CI 0.90–1.63, I 2 = 21.1%), see Fig. 6.

Table 2.

Lesion locations significantly associated with post-stroke depression and post-stroke apathy

Lesion location Studies
Acute phase Post-acute phase Chronic phase
PSD
Anterior Astrom et al. (1993); Herrmann et al. (1993); Shimoda and Robinson (1999) Dam et al. (1989); House et al. (1990); Kim and Choi-Kwon (2000); Morris et al. (1992); Shimoda and Robinson (1999) House et al. (1990)
Frontal lobe Metoki et al. (2016); Robinson et al. (1984); Shi et al. (2014) Aben et al. (2006); Effat et al. (2011); Hama et al. (2007b); Morris et al. (1996b); Murakami et al. (2013); Singh et al. (2000); Stojanovic and Stojanovic (2015); Tang et al. (2010); Wichowicz et al. (2015); Zhang et al. (2012) –
Temporal lobe Metoki et al. (2016); Terroni et al. (2015) Zhang et al. (2012) –
Posterior (occipital, parietal lobe) Metoki et al. (2016); Paradiso and Robinson (1999); Starkstein et al. (1989) Schwartz et al. (1993) Shimoda and Robinson (1999)
Subcortical Shi et al. (2014) Schwartz et al. (1993); Tang et al. (2005); Zhang et al. (2012) Chatterjee et al. (2010)
Basal ganglia Herrmann et al. (1993); Yang et al. (2015b); Metoki et al. (2016) Herrmann et al. (1995); Morris et al. (1996b); Nishiyama et al. (2010); Murakami et al. (2013); Wichowicz et al. (2015) –
Insular cortex Yang et al. (2015b) – –
Brainstem – Murakami et al. (2013) –
Left hemisphere Robinson et al. (1984); Robinson et al. (1985); Astrom et al. (1993); Morris et al. (1996a); Paradiso and Robinson (1999); Shimoda and Robinson (1999); Saxena and Suman (2015); Wongwandee et al. (2012) Barker-Collo (2007); Jiang et al. (2014); Morris et al. (1996b); Rajashekaran et al. (2013); Wichowicz et al. (2015) Parikh et al. (1988); Provinciali et al. (2008); Rashid et al. (2013); Stern and Bachman (1991)
Right hemisphere Yang et al. (2015b) Andersen et al. (1995); Castellanos-Pinedo et al. (2011); Dam et al. (1989); MacHale et al. (1998); Oladiji et al. (2009); Schwartz et al. (1993); Singh et al. (2000) Stern and Bachman (1991); Verdelho et al. (2004)
Infratentorial – Iranmanesh and Vakilian (2009) –
ACA – Desmond et al. (2003); Jiang et al. (2014); Tang et al. (2005) Provinciali et al. (2008)
PCA – Desmond et al. (2003) –
PSA
Basal ganglia Onoda et al. (2011) Hama et al. (2007b); Mihalov et al. (2016); Murakami et al. (2013); Santa et al. (2008) Rochat et al. (2013)
Thalamus – – Rochat et al. (2013)
Pons / brainstem – Murakami et al. (2013); Tang et al. (2013a) –
Right hemisphere – Castellanos-Pinedo et al. (2011) –
Left hemisphere Kang and Kim (2008) – –
Frontal lobe Kang and Kim (2008) – –
CC / CG Kang and Kim (2008) – –
IC (posterior limb) Starkstein et al. (1993) – –
Open in a new tab

ACA anterior circulation area, CC corpus callosum, CG cingulate gyrus, IC internal capsule, PCA posterior circulation area, PSA post-stroke apathy, PSD post-stroke depression

Fig. 6.

Fig. 6

Open in a new tab

Forest plot of the relationship between post-stroke depression and frontal/anterior lesions. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels) and post-acute stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Ten (8%) studies reported outcomes on subcortical lesion location associated with PSD. Pooled odds for PSD were not significantly higher after subcortical lesions (Table 1). A subgroup analysis by study phase showed no significant associations between subcortical lesions and PSD in the acute (OR 1.04, 95% CI 0.64–1.70), post-acute (OR 0.93, 95% CI 0.65–1.32), or chronic stroke phase (OR 1.88, 95% CI 0.92–3.84), see Fig. 7a), but the latter association consisted only of two studies. No significant heterogeneity was observed (each phase, I 2 = 0.0%). Twelve (9%) studies reported outcomes on basal ganglia lesion location associated with PSD. Overall, basal ganglia lesions were significantly associated with PSD (Table 1). A subgroup analysis by study phase showed that basal ganglia lesions were significantly associated with PSD in the post-acute phase (OR 2.25, 95% CI 1.33–3.84, I 2 = 71.2%), but not in the acute stroke phase (OR 1.26, 95% CI 0.74–2.14, I 2 = 41.4%), see Fig. 7b).

Fig. 7.

Fig. 7

Open in a new tab

Forest plot of the relationship between post-stroke depression and subcortical/basal ganglia lesions. In panel a, the results of the meta-analysis on subcortical lesion location are presented. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels), post-acute stroke phase (middle panels), and chronic stroke phase (lower panels) are presented. In panel b, the results of the meta-analysis on basal ganglia lesions are presented. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels) and post-acute stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Five (22%) studies provided data on the association between PSA and frontal lesions. Overall, no significant association between PSA and frontal lesions was found (Table 1). Subgroup analyses showed different albeit no significant results per phase, with stronger associations with frontal lesions in the acute phase (OR 1.68, 95% CI 0.52–5.45, I 2 = 0.0%), and an inverse relation in the post-acute phase (OR 0.63, 95% CI 0.29–1.34, I 2 = 0.0%), see Fig. 8a. No significant association between PSA and subcortical lesions was found (Table 1), but this was only evaluated in two (9%) studies (OR 1.03, 95% CI 0.38–2.80, I 2 = 0.0%), see Fig. 8b. Four (17%) studies provided data on the association between PSA and basal ganglia lesions. Overall, no significant association between PSA and basal ganglia lesions was found (Table 1). Stratification by study phase showed similar results, with no significant heterogeneity (acute phase: OR 1.45, 95% CI 0.42–4.95, post-acute phase: OR 1.29, 95% CI 0.73–2.29), see Fig. 8c.

Fig. 8.

Fig. 8

Open in a new tab

Forest plot of the relationship between post-stroke apathy and lesion location. In panel a, the results of the meta-analysis on frontal lesion location are presented. In panel b, the results of the meta-analysis on subcortical lesion location are presented. In panel c, the results of the meta-analysis on basal ganglia lesions are presented. Apart from the overall analysis, the subanalyses on acute stroke phase (upper panels) and post-acute stroke phase (lower panels) are presented. CI confidence interval, OR odds ratio

Other Imaging Markers

Several studies examined imaging markers other than lesion location and type in association with PSD. These markers could not be evaluated in a meta-analysis. Therefore, the most important imaging markers are described qualitatively (see Table 3). PSD was associated with total (Chatterjee et al. 2010; Pavlovic et al. 2016), deep (Pavlovic et al. 2016), frontal (Chatterjee et al. 2010; Mok et al. 2010), and periventricular WMH (Pavlovic et al. 2016). Also, cerebral microbleeds are associated with PSD (Choi-Kwon et al. 2012; Tang et al. 2014a; Tang et al. 2011a, b, 2014b), and several studies showed that PSD is more prevalent in patients with a large lesion volume (Hama et al. 2007b; Ku et al. 2013; MacHale et al. 1998; Morris et al. 1992; Nys et al. 2005; Schwartz et al. 1993; Sharpe et al. 1990, 1994; Shimoda and Robinson 1999; Zhang et al. 2012) or large number of lesions (Bendsen et al. 1997; Chatterjee et al. 2010; Jiang et al. 2014; Pavlovic et al. 2016; Tang et al. 2014b; Zhang et al. 2012).

Table 3.

Imaging markers associated with post-stroke depression and post-stroke apathy

Imaging marker Studies
Acute phase Post-acute phase Chronic phase
PSD
Degree of WMH – Deep WMH: Kim et al. (2011); Tang et al. (2010) Overall, BG, frontal WMC: Chatterjee et al. (2010)
Left frontal WMH: Mok et al. (2010) Overall, deep, periventricular WMH: Pavlovic et al. (2016)
Cerebral microbleeds Choi-Kwon et al. (2012) Tang et al. (2011a, b, 2014a, b) –
Large lesion volume Shimoda and Robinson (1999); Ku et al. (2013); Nys et al. (2005) Hama et al. (2007b); MacHale et al. (1998); Morris et al. (1992); Schwartz et al. (1993); Shimoda and Robinson (1999); Zhang et al. (2012) Sharpe et al. (1990, 1994); Shimoda and Robinson (1999)
Large number of lesions – Bendsen et al. (1997); Jiang et al. (2014); Tang et al. (2014b); Zhang et al. (2012) Chatterjee et al. (2010); Lacunar lesions: Pavlovic et al. (2016)
Metabolism Huang et al. (2010); Xu et al. (2008) Glodzik-Sobanska et al. (2006); Wang et al. (2012); Xu et al. (2008) –
Atrophy – Left IFG: Fu et al. (2010) FL: Tang et al. (2013b) Subcortical: Astrom et al. (1993); Starkstein et al. (1988)
Regional cerebral blood flow – Left hemisphere: Wichowicz et al. (2006) –
Functional connectivity / fractional anisotropy Altered FC in left orbital part of IFG: Zhang et al. (2014) Frontal WM integrity: Williamson et al. (2010); Increased ratio FA values in bilateral anterior limbs of IC: Yasuno et al. (2014) –
PSA
Degree of WMH – RH WMH, right fronto-subcortical circuit WMH: Brodaty et al. (2005); Periventricular WMH: Tang et al. (2013a) –
Large lesion volume – Hama et al. (2007b) –
Large number of lesions – Tang et al. (2013a) –
Metabolism Glodzik-Sobanska et al. (2005) – –
Regional cerebral blood flow Bilateral BG: Onoda et al. (2011) – Right dlF and lFT: Okada et al. (1997)
Fractional anisotropy – Reduced FA in Genu of CC, left anterior corona radiata, splenium of CC, and WM in the right IFG: Yang et al. (2015c). Reduced median FA, reduction in WM integrity in anterior cingulum, fornix and uncinate fasciculus: Hollocks et al. (2015) –
Atrophy – Frontal cortical atrophy: Mihalov et al. (2016) –
Open in a new tab

ATR atrophy, BG basal ganglia, CC corpus collosum, CMB cerebral microbleeds, dlF dorsolateral frontal, FA fractional anisotropy, FC functional connectivity, FL frontal lobe, IFG inferior frontal gyrus, lFT left frontotemporal, RH right hemisphere, WM white matter, WMC white matter changes, WMH white matter hyperintensities, PSA post-stroke apathy, PSD post-stroke depression

More recently, advanced diffusion tensor imaging (DTI) techniques have been used to investigate the association between microstructural abnormalities in white matter (WM) and PSD. Yasuno et al. (2014) showed that a reduction in fractional anisotropy (FA) in the bilateral anterior limbs of the internal capsule was associated with an increased risk of PSD and Williamson et al. (2010) showed that decreased WM integrity in the frontal lobes was associated with mood deficits. This indicates that WM damage in certain brain regions is associated with the development of PSD. A resting-state functional MRI (fMRI) study showed that altered functional connectivity in regions involved in affect was associated with higher levels of depression (Zhang et al. 2014). Atrophy also seems to be an important predictor of PSD, as significant associations were found with frontal lobe atrophy (Tang et al. 2013b), subcortical atrophy (Astrom et al. 1993; Starkstein et al. 1988), and left inferior frontal gyrus atrophy (Fu et al. 2010). Interestingly, none of these studies reported on hippocampal atrophy. Recently, Chen et al. (2016) looked at medial temporal lobe atrophy, but found no association with PSD in the acute or post-acute stroke phase. According to proton magnetic resonance spectroscopy (1H–MRS) studies, biochemical changes in metabolite levels in frontal lobe (Glodzik-Sobanska et al. 2006; Wang et al. 2012; Xu et al. 2008), hippocampus (Huang et al. 2010), and left thalamus (Huang et al. 2010) seem to accompany the development of PSD.

Compared with PSD studies, only few studies evaluated imaging markers related to PSA (see Table 3). PSA was significantly associated with degree of right-hemisphere (Brodaty et al. 2005), right fronto-subcortical circuit (Brodaty et al. 2005), and periventricular WMH (Tang et al. 2013a). In addition, large lesion volume (Hama et al. 2007b), and large number of lesions (Tang et al. 2013a) were associated with PSA. A recent study by Mihalov et al. (2016) showed that frontal cortical atrophy was a strong predictor of PSA, and this relation increased with higher age. In two DTI studies reductions in FA in several brain areas were associated with an increased level of apathy (Yang et al. 2015c). In addition, PSA was associated with reductions in regional cerebral blood flow in the bilateral basal ganglia (Onoda et al. 2011), right dorsolateral frontal cortex, and left frontotemporal cortex (Okada et al. 1997) measured with single-photon emission computed tomography. An H1-MRS study suggested that lower N-acetylaspartate/creatine ratio in the right frontal lobe was related to PSA (Glodzik-Sobanska et al. 2005).

Meta-Regression Analyses

Egger’s regression tests showed no evidence for statistically significant small-study effects in above meta-analyses (see Table 1), although it was not possible to calculate Egger’s regression coefficients for the association with subcortical lesions in PSA as the pooled sample size was too small. Visual inspection of the shape of the funnel plots also did not reveal convincing evidence of obvious asymmetry (see supplementary Online Resource 6). However, some plots, especially for the PSA studies, only consisted of few studies.

Meta-regression analyses were performed to assess potential sources of heterogeneity between PSD studies reporting on lesion laterality (n = 60). None of the included variables appeared to be a significant cause of heterogeneity. In addition, meta-regression analyses were performed on PSD studies reporting on frontal (n = 30) and basal ganglia lesions (n = 12). Only study phase appeared to be a significant cause of heterogeneity in both analyses (frontal: p = 0.041, residual I 2 = 58.9%, Adj. R 2 = 25.7%; basal ganglia: p = 0.044, residual I 2 = 55.4%, Adj. R 2 = 50.7%). To assess potential sources of heterogeneity among PSA studies reporting on lesion laterality (n = 9), meta-regression analyses were performed showing that only imaging method appeared to be an important cause of heterogeneity (p = 0.052, residual I 2 = 31.2%, Adj. R 2 = 64.6%).

Discussion

This systematic review and meta-analysis summarizes the most up-to-date information on a range of imaging markers associated with PSD and PSA during the acute, post-acute, and chronic stroke phase. Meta-analyses indicated that PSD in the post-acute phase was significantly more frequent in patients with frontal or basal ganglia lesions. No significant association was found between PSD and lesion laterality in the post-acute and chronic stroke phase. Nevertheless, it is of interest to mention that left-sided stroke occurred more often in the PSD group in the acute phase. This result became insignificant after the inclusion of four recent large studies (Chen et al. 2016; Metoki et al. 2016; Wei et al. 2016; Zhang et al. 2016), which differed from the other studies in that they reported a relatively low PSD prevalence (median 18.6%, IQR 17.4–30.2). Frequency of PSD was equal for ischemic and hemorrhagic stroke in all stroke phases, but PSA was more frequent after hemorrhagic stroke in the acute phase, whereas it was more frequent after ischemic stroke in the post-acute phase. Since only four PSA studies were available, this finding should be interpreted with caution. Also, PSA did not depend on lesion laterality or location, but again the amount of available PSA studies was small in general.

Our meta-analysis updates and extends previous studies. The meta-analysis by Wei et al. (2015) on lesion laterality and PSD found a significant association between right hemispheric lesions and risk of PSD in the post-acute stroke phase (1–6 months). In contrast to Wei et al. (2015), we defined the post-acute period as 15 days to 6 months, which could explain the difference in results. In agreement with Caeiro et al. (2013a) the prevalence of PSA was not associated with lesion laterality. Both meta-analyses did not study associations with markers other than lesion laterality and lesion type, while the review of van Dalen et al. (2013) evaluated associations between PSA and lesion location only qualitatively and concluded that no clear association could be found.

The present findings suggest that lesion location is an important risk factor for PSD in the post-acute stroke phase. However, in the past few years the hypothesis of PSD and PSA being associated with damage to specific lesion locations has been shifted to the idea that damage to a neuronal network involved in affect is underlying the development of PSD and PSA (Tang et al. 2011c; Terroni et al. 2011; Vataja et al. 2001), with different sub-circuits involved in PSD (Yang et al. 2015b) and PSA (Yang et al. 2015a), see Table 4. DTI is a promising tool to identify more accurately how these brain networks are affected after stroke. The qualitative overview of imaging markers associated with PSD and PSA showed that not only direct stroke-related features such as lesion location, lesion volume, and number of lesions, but also other neurovascular, non-directly stroke-related but often co-occurring features, such as degree of WMH, cerebral microbleeds, and atrophy, were frequently associated with PSD. With respect to PSA, associations with degree of WMH, lesion volume, and number of lesions were found in some extent. Co-occurring vascular lesions may make a stroke patient more vulnerable for developing PSD and PSA. Therefore, future studies should focus on a broader range of imaging markers, including lesion volume, atrophy, WMH, and cerebral microbleeds, and also how lesion-related markers may interact with co-occuring indirect vascular markers. Besides, advanced imaging techniques (e.g. DTI, fMRI) are needed to evaluate how microstructural abnormalities and changes in functional connectivity contribute to the development of PSD and PSA.

Table 4.

Circuits associated with post-stroke depression and post-stroke apathy

Studies Phase Circuits - network
PSD
 Terroni et al. (2011) Acute Disruption of limbic-cortical-striatal-pallidal-thalamic circuit, Medial PFC dysfunction
  Yang et al. (2015b) Acute Frontal lobe, insula, limbic system, parietal lobe, basal ganglia, temporal lobe
  Vataja et al. (2001) Post-acute Higher number and lesion volume in (left) prefronto-subcortical circuit
  Tang et al. (2011c) Post-acute Lesions in frontal subcortical circuits
PSA
  Yang et al. (2015a) Acute Limbic system, basal ganglia, insula, frontal, temporal, parietal, occipital lobe
Open in a new tab

PFC prefrontal cortex, PSA post-stroke apathy, PSD post-stroke depression

Our study has the following strengths. A large amount of publications on PSD were identified, resulting in a rich pooled cohort of studies that were not included in earlier meta-analyses (Chen et al. 2013, 2016; Gozzi et al. 2014; Jiang et al. 2014; Metoki et al. 2016; Saxena and Suman 2015; Terroni et al. 2015; Wei et al. 2016; Wichowicz et al. 2015; Zhang et al. 2016). Furthermore, beside information on lesion laterality, also data on other imaging markers was retrieved for quantitative and qualitative analysis. Therefore, the present review provides an up-to-date and extended overview of findings on the association between imaging markers and risk of PSD and PSA.

One limitation of the present study was the small amount of studies on PSA, which made it difficult to perform sub-analyses. Therefore, future studies are needed on imaging markers of PSA, covering a broad range of imaging markers. Nevertheless, as heterogeneity was small between PSA studies, we believe that the results are still of importance, but should be interpreted with caution as the generalizability and validity is compromised in comparison with meta-analyses including a larger amount of studies. In addition, moderate to high (unexplained) heterogeneity between studies in some meta-analyses indicated large differences in methodology between studies. Particularly the use of different scales and cut-offs to define the presence of depression and apathy and different imaging methods (CT vs. MRI) are of influence on the comparability of findings. Also differences in eligibility criteria (e.g. exclusion of patients with aphasia, differences in age range) can create heterogeneity among studies. Meta-regression analyses were performed to identify potential sources of heterogeneity, and only study phase for PSD studies and imaging method for PSA studies could be identified. However, in addition to the included variables, also other potential variables (e.g. years of education, cognitive status), that could not be included in the analyses due to the large variability in the methods and availability of data between studies, might explain some of the between-study difference in effect estimates. Therefore, we performed random-effects meta-analyses, which take the heterogeneity between studies into account.

Conclusion

The present study suggests that lesion location rather than lesion laterality or type may be an important risk factor for PSD in the post-acute stroke phase. In contrast, lesion type rather than lesion laterality or location might be an important factor in determining who is at risk to develop PSA in the acute and post-acute phase, though additional studies are needed to confirm this, as the sample size was small. Therefore, large multicenter cohort studies using advanced imaging techniques and focusing on both PSD and PSA from the acute to the chronic stroke phase are strongly needed.

Electronic supplementary material

ESM 1 (125.1KB, docx)

(DOCX 125 kb)

ESM 2 (143.5KB, docx)

(DOCX 143 kb)

ESM 3 (147.7KB, docx)

(DOCX 147 kb)

ESM 4 (169.8KB, docx)

(DOCX 169 kb)

ESM 5 (135.7KB, docx)

(DOCX 135 kb)

ESM 6 (347.8KB, docx)

(DOCX 347 kb)

ESM 7 (63.5KB, doc)

(DOC 63 kb)

Compliance with Ethical Standards

Conflict of Interest

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Financial Disclosure

Funding was received from Maastricht University, Health Foundation Limburg, and the Adriana van Rinsum Ponsen Stichting.

Footnotes

Electronic supplementary material

The online version of this article (doi:10.1007/s11065-017-9356-2) contains supplementary material, which is available to authorized users.

References

  1. Aben I, Ladder J, Honig A, Lousberg R, Boreas A, Verhey FRJ. Focal or generalized vascular brain damage and vulnerability to depression after stroke: a 1-year prospective follow-up study. International Psychogeriatrics. 2006;18(1):19–35. doi: 10.1017/S104161020500270X. [DOI] [PubMed] [Google Scholar]
  2. Akiashvili N, Beridze M, Janelidze M, Lobjanidze N, Kvirkvelia N. Cognitive outcome in multiple silent lacunar lesions and stroke in geriatric patients. Cerebrovascular Diseases. 2013;36:76. [Google Scholar]
  3. American Psychiatric Association . DSM-III: Diagnostic and statistical manual of psychiatric disorders. Washington, DC: American Psychiatric Association; 1980. [Google Scholar]
  4. American Psychiatric Association . DSM-IV: Diagnostic and statistic manual of mental disorders. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
  5. Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatrica Scandinavica. 1995;92(3):193–198. doi: 10.1111/j.1600-0447.1995.tb09567.x. [DOI] [PubMed] [Google Scholar]
  6. Andersson S, Krogstad J, Finset A. Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychological Medicine. 1999;29(02):447–456. doi: 10.1017/s0033291798008046. [DOI] [PubMed] [Google Scholar]
  7. Astrom M. Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke. 1996;27(2):270–275. doi: 10.1161/01.str.27.2.270. [DOI] [PubMed] [Google Scholar]
  8. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993;24(7):976–982. doi: 10.1161/01.str.24.7.976. [DOI] [PubMed] [Google Scholar]
  9. Aziz NA. Long-term rehabilitation after stroke: where do we go from here? Reviews in Clinical Gerontology. 2010;20(03):239–245. [Google Scholar]
  10. Barker-Collo SL. Depression and anxiety 3 months post stroke: prevalence and correlates. Archives of Clinical Neuropsychology. 2007;22(4):519–531. doi: 10.1016/j.acn.2007.03.002. [DOI] [PubMed] [Google Scholar]
  11. Beblo T, Wallesch C-W, Herrmann M. The crucial role of frontostriatal circuits for depressive disorders in the postacute stage after stroke. Neuropsychiatry, Neuropsychology, & Behavioral Neurology. 1999;12(4):236–246. [PubMed] [Google Scholar]
  12. Beckson M, Cummings JL. Neuropsychiatric aspects of stroke. International Journal of Psychiatry in Medicine. 1991;21(1):1–15. doi: 10.2190/EUMY-3MGP-MWB2-CWG9. [DOI] [PubMed] [Google Scholar]
  13. Bella R, Pennisi G, Cantone M, Palermo F, Pennisi M, Lanza G, et al. Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease. Gerontology. 2010;56(3):298–302. doi: 10.1159/000272003. [DOI] [PubMed] [Google Scholar]
  14. Bendsen BB, Bendsen EB, Lauritzen L, Vilmar T, Bech P. Post-stroke patients in rehabilitation. The relationship between biological impairment (CT scanning), physical disability and clinical depression. European Psychiatry. 1997;12(8):399–404. doi: 10.1016/S0924-9338(97)83565-1. [DOI] [PubMed] [Google Scholar]
  15. Brodaty H, Sachdev PS, Withall A, Altendorf A, Valenzuela MJ, Lorentz L. Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke--the Sydney Stroke Study. Psychological Medicine. 2005;35(12):1707–1716. doi: 10.1017/S0033291705006173. [DOI] [PubMed] [Google Scholar]
  16. Buisman LR, Tan SS, Nederkoorn PJ, Koudstaal PJ, Redekop WK. Hospital costs of ischemic stroke and TIA in the Netherlands. Neurology. 2015;84(22):2208–2215. doi: 10.1212/WNL.0000000000001635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Caeiro L, Ferro JM, Figueira ML. Apathy in acute stroke patients. European Journal of Neurology. 2012;19(2):291–297. doi: 10.1111/j.1468-1331.2011.03508.x. [DOI] [PubMed] [Google Scholar]
  18. Caeiro L, Ferro JM, Costa J. Apathy secondary to stroke: a systematic review and meta-analysis. Cerebrovascular Diseases. 2013;35(1):23–39. doi: 10.1159/000346076. [DOI] [PubMed] [Google Scholar]
  19. Caeiro L, Ferro JM, Pinho e Melo T, Canhão P, Figueira ML. Post-stroke apathy: an exploratory longitudinal study. Cerebrovascular Diseases. 2013;35(6):507–513. doi: 10.1159/000350202. [DOI] [PubMed] [Google Scholar]
  20. Carod-Artal J, Egido JA, González JL, De Seijas EV. Quality of life among stroke survivors evaluated 1 year after stroke Experience of a stroke unit. Stroke. 2000;31(12):2995–3000. doi: 10.1161/01.str.31.12.2995. [DOI] [PubMed] [Google Scholar]
  21. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. The Lancet. 2000;356(9224):122–126. doi: 10.1016/S0140-6736(00)02448-X. [DOI] [PubMed] [Google Scholar]
  22. Castellanos-Pinedo F, Hernandez-Perez JM, Zurdo M, Rodriguez-Funez B, Hernandez-Bayo JM, Garcia-Fernandez C, et al. Influence of Premorbid psychopathology and lesion location on affective and behavioral disorders after ischemic stroke. Journal of Neuropsychiatry and Clinical Neurosciences. 2011;23(3):340–347. doi: 10.1176/jnp.23.3.jnp340. [DOI] [PubMed] [Google Scholar]
  23. Chatterjee, K., Fall, S., & Barer, D. (2010). Mood after stroke: A case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors. BMC Neurology, 10(125), 1–10. doi: 10.1186/1471-2377-10-125. [DOI] [PMC free article] [PubMed]
  24. Chen Y, Chen LF, Tao YQ, Zhou FX, Cui CL, Liu SC. Investigation of prevalence and risk factors of depressive symptoms following acute ischemic stroke in the aged. Journal of the American Geriatrics Society. 2013;61:S358. [Google Scholar]
  25. Chen Y-K, Qu J-F, Xiao W-M, Li W-Y, Li W, Fang X-W, et al. Intracranial atherosclerosis and poststroke depression in Chinese patients with ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2016;25(4):998–1004. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.038. [DOI] [PubMed] [Google Scholar]
  26. Choi-Kwon S, Han K, Choi S, Suh M, Kim YJ, Song H, et al. Poststroke depression and emotional incontinence: factors related to acute and subacute stages. Neurology. 2012;78(15):1130–1137. doi: 10.1212/WNL.0b013e31824f8090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dam H, Pedersen HE, Ahlgren P. Depression among patients with stroke. Acta Psychiatrica Scandinavica. 1989;80(2):118–124. doi: 10.1111/j.1600-0447.1989.tb01312.x. [DOI] [PubMed] [Google Scholar]
  28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  29. Desmond DW, Remien RH, Moroney JT, Stern Y, Sano M, Williams JB. Ischemic stroke and depression. Journal of the International Neuropsychological Society. 2003;9(3):429–439. doi: 10.1017/S1355617703930086. [DOI] [PubMed] [Google Scholar]
  30. Downhill JE, Jr, Robinson RG. Longitudinal assessment of depression and cognitive impairment following stroke. Journal of Nervous & Mental Disease. 1994;182(8):425–431. doi: 10.1097/00005053-199408000-00001. [DOI] [PubMed] [Google Scholar]
  31. Effat SM, Mohamed MM, El Essawy HI, El Sheikh MM, Abdul Aal HS. Predictors and consequences of post-stroke depression in a sample of Egyptian patients. Arab Journal of Psychiatry. 2011;22(1):19–26. [Google Scholar]
  32. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Eriksen S, Gay CL, Lerdal A. Acute phase factors associated with the course of depression during the first 18 months after first-ever stroke. Disability and Rehabilitation. 2016;38(1):30–35. doi: 10.3109/09638288.2015.1009181. [DOI] [PubMed] [Google Scholar]
  34. Fu JH, Wong K, Mok V, Hu X, Xiong Y, Chen Y, et al. Neuroimaging predictors for depressive symptoms in cerebral small vessel disease. International Journal of Geriatric Psychiatry. 2010;25(10):1039–1043. doi: 10.1002/gps.2436. [DOI] [PubMed] [Google Scholar]
  35. Glodzik-Sobanska L, Slowik A, Kieltyka A, Kozub J, Sobiecka B, Urbanik A, et al. Reduced prefrontal N-acetylaspartate in stroke patients with apathy. Journal of the Neurological Sciences. 2005;238(1–2):19–24. doi: 10.1016/j.jns.2005.06.004. [DOI] [PubMed] [Google Scholar]
  36. Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, et al. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Research: Neuroimaging. 2006;148(2–3):111–120. doi: 10.1016/j.pscychresns.2006.08.004. [DOI] [PubMed] [Google Scholar]
  37. Gozzi, S. A., Wood, A. G., Chen, J., Vaddadi, K., & Phan, T. G. (2014). Imaging predictors of poststroke depression: methodological factors in voxel-based analysis. BMJ Open, 4(7). doi: 10.1136/bmjopen-2014-004948. [DOI] [PMC free article] [PubMed]
  38. Grasso MG, Pantano P, Ricci M, Intiso DF, Pace A, Padovani A, et al. Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke. Stroke. 1994;25(5):980–985. doi: 10.1161/01.str.25.5.980. [DOI] [PubMed] [Google Scholar]
  39. Grool AM, Gerritsen L, Zuithoff NP, Mali WP, van der Graaf Y, Geerlings MI. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up. Biological Psychiatry. 2013;73(2):169–176. doi: 10.1016/j.biopsych.2012.08.024. [DOI] [PubMed] [Google Scholar]
  40. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke a systematic review of observational studies. Stroke. 2005;36(6):1330–1340. doi: 10.1161/01.STR.0000165928.19135.35. [DOI] [PubMed] [Google Scholar]
  41. Hackett ML, Köhler S, O'Brien JT, Mead GE. Neuropsychiatric outcomes of stroke. The Lancet Neurology. 2014;13(5):525–534. doi: 10.1016/S1474-4422(14)70016-X. [DOI] [PubMed] [Google Scholar]
  42. Hama S, Yamashita H, Shigenobu M, Watanabe A, Hiramoto K, Kurisu K, et al. Depression or apathy and functional recovery after stroke. International Journal of Geriatric Psychiatry. 2007;22(10):1046–1051. doi: 10.1002/gps.1866. [DOI] [PubMed] [Google Scholar]
  43. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, et al. Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. European Archives of Psychiatry & Clinical Neuroscience. 2007;257(3):149–152. doi: 10.1007/s00406-006-0698-7. [DOI] [PubMed] [Google Scholar]
  44. Hama S, Yamashita H, Yamawaki S, Kurisu K. Post-stroke depression and apathy: interactions between functional recovery, lesion location, and emotional response. Psychogeriatrics. 2011;11(1):68–76. doi: 10.1111/j.1479-8301.2011.00358.x. [DOI] [PubMed] [Google Scholar]
  45. Hama S, Murakami T, Yamashita H, Onoda K, Yamawaki S, Kurisu K. Neuroanatomic pathways associated with monoaminergic dysregulation after stroke. International Journal of Geriatric Psychiatry. 2016;23(6):633–642. doi: 10.1002/gps.4503. [DOI] [PubMed] [Google Scholar]
  46. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry. 1960;23(1):56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Herrmann M, Bartels C, Wallesch C-W. Depression in acute and chronic aphasia: symptoms, pathoanatomical-clinical correlations and functional implications. Journal of Neurology, Neurosurgery & Psychiatry. 1993;56(6):672–678. doi: 10.1136/jnnp.56.6.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Herrmann M, Bartels C, Schumacher M, Wallesch CW. Poststroke depression. Is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke. 1995;26(5):850–856. doi: 10.1161/01.str.26.5.850. [DOI] [PubMed] [Google Scholar]
  49. Hollocks M, Lawrence A, Brookes R, Barrick T, Morris R, Husain M, et al. Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain: A Journal of Neurology. 2015;138(Pt 12):3803–3815. doi: 10.1093/brain/awv304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. House A, Dennis M, Warlow C, Hawton K, Molyneux A. Mood disorders after stroke and their relation to lesion location. A CT scan study. Brain. 1990;113(Pt 4):1113–1129. doi: 10.1093/brain/113.4.1113. [DOI] [PubMed] [Google Scholar]
  51. Huang Y, Chen W, Li Y, Wu X, Shi X, Geng D. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using 1H magnetic resonance spectroscopy. Psychiatry Research: Neuroimaging. 2010;182(1):48–52. doi: 10.1016/j.pscychresns.2009.11.009. [DOI] [PubMed] [Google Scholar]
  52. Iranmanesh F, Vakilian A. Post stroke depression among Iranian patients. Neurosciences. 2009;14(2):148–151. [PubMed] [Google Scholar]
  53. Jiang XG, Lin Y, Li YS. Correlative study on risk factors of depression among acute stroke patients. European Review for Medical & Pharmacological Sciences. 2014;18(9):1315–1323. [PubMed] [Google Scholar]
  54. Kang SY, Kim JS. Anterior cerebral artery infarction stroke mechanism and clinical-imaging study in 100 patients. Neurology. 2008;70(24 Part 2):2386–2393. doi: 10.1212/01.wnl.0000314686.94007.d0. [DOI] [PubMed] [Google Scholar]
  55. Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology. 2000;54(9):1805–1810. doi: 10.1212/wnl.54.9.1805. [DOI] [PubMed] [Google Scholar]
  56. Kim JT, Park MS, Yoon GJ, Jung HJ, Choi KH, Nam TS, et al. White matter hyperintensity as a factor associated with delayed mood disorders in patients with acute ischemic stroke. European Neurology. 2011;66(6):343–349. doi: 10.1159/000332585. [DOI] [PubMed] [Google Scholar]
  57. Ku H-L, Chen C-H, Yang Y-T, Hu C-J, Wu D, Chen C-C, et al. Association between cerebral lesions and emotional changes in acute ischemic stroke patients. Journal of Nervous and Mental Disease. 2013;201(5):400–406. doi: 10.1097/NMD.0b013e31828e0fe9. [DOI] [PubMed] [Google Scholar]
  58. Kutlubaev MA, Hackett ML. Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. International Journal of Stroke. 2014;9(8):1026–1036. doi: 10.1111/ijs.12356. [DOI] [PubMed] [Google Scholar]
  59. Lassalle-Lagadec S, Sibon I, Dilharreguy B, Renou P, Fleury O, Allard M. Subacute default mode network dysfunction in the prediction of post-stroke depression severity. Radiology. 2012;264(1):218–224. doi: 10.1148/radiol.12111718. [DOI] [PubMed] [Google Scholar]
  60. Lassalle-Lagadec S, Catheline G, Mayo W, Dilharreguy B, Renou P, Fleury O, et al. Cerebellum involvement in post-stroke mood: a combined ecological and MRI study. Psychiatry Research: Neuroimaging. 2013;212(2):158–160. doi: 10.1016/j.pscychresns.2013.01.003. [DOI] [PubMed] [Google Scholar]
  61. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, et al. Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences. 1998;10(3):314–319. doi: 10.1176/jnp.10.3.314. [DOI] [PubMed] [Google Scholar]
  62. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine. 2009;151(4):W-65–W-94. doi: 10.7326/0003-4819-151-4-200908180-00136. [DOI] [PubMed] [Google Scholar]
  63. MacHale SM, O'Rourke SJ, Wardlaw JM, Dennis MS. Depression and its relation to lesion location after stroke. Journal of Neurology, Neurosurgery & Psychiatry. 1998;64(3):371–374. doi: 10.1136/jnnp.64.3.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Marin RS. Differential diagnosis and classification of apathy. The American Journal of Psychiatry. 1990;147(1):22–30. doi: 10.1176/ajp.147.1.22. [DOI] [PubMed] [Google Scholar]
  65. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Research. 1991;38(2):143–162. doi: 10.1016/0165-1781(91)90040-v. [DOI] [PubMed] [Google Scholar]
  66. Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. Journal of Affective Disorders. 1993;28(2):117–124. doi: 10.1016/0165-0327(93)90040-q. [DOI] [PubMed] [Google Scholar]
  67. Matsuoka K, Yasuno F, Taguchi A, Yamamoto A, Kajimoto K, Kazui H, et al. Delayed atrophy in posterior cingulate cortex and apathy after stroke. International Journal of Geriatric Psychiatry. 2015;30(6):566–572. doi: 10.1002/gps.4185. [DOI] [PubMed] [Google Scholar]
  68. Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, Starkstein SE, et al. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. American Journal of Psychiatry. 1988;145(8):937–943. doi: 10.1176/ajp.145.8.937. [DOI] [PubMed] [Google Scholar]
  69. Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke. 2009;40(10):3299–3307. doi: 10.1161/STROKEAHA.109.554410. [DOI] [PubMed] [Google Scholar]
  70. Metoki N, Sugawara N, Hagii J, Saito S, Shiroto H, Tomita T, et al. Relationship between the lesion location of acute ischemic stroke and early depressive symptoms in Japanese patients. Annals of General Psychiatry. 2016;15(12):1–6. doi: 10.1186/s12991-016-0099-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Mihalov, J., Mikula, P., Budiš, J., & Valkovič, P. (2016). Frontal Cortical Atrophy as a Predictor of Poststroke Apathy. Journal of Geriatric Psychiatry and Neurology, 29(4), 171–176. [DOI] [PubMed]
  72. Mok VC, Wong A, Wong K, Chu WC, Xiong Y, Chan AY, et al. Executive dysfunction and left frontal white matter hyperintensities are correlated with neuropsychiatric symptoms in stroke patients with confluent white matter hyperintensities. Dementia & Geriatric Cognitive Disorders. 2010;30(3):254–260. doi: 10.1159/000318744. [DOI] [PubMed] [Google Scholar]
  73. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry. 1979;134(4):382–389. doi: 10.1192/bjp.134.4.382. [DOI] [PubMed] [Google Scholar]
  74. Morris PL, Robinson RG, Raphael B. Lesion location and depression in hospitalized stroke patients: Evidence supporting a specific relationship in the left hemisphere. Neuropsychiatry, Neuropsychology, & Behavioral Neurology. 1992;5(2):75–82. [Google Scholar]
  75. Morris PL, Robinson RG, de Carvalho ML, Albert P, Wells JC, Samuels JF, et al. Lesion characteristics and depressed mood in the stroke data bank study. Journal of Neuropsychiatry & Clinical Neurosciences. 1996;8(2):153–159. doi: 10.1176/jnp.8.2.153. [DOI] [PubMed] [Google Scholar]
  76. Morris PLP, Robinson RG, Raphael B, Hopwood MJ. Lesion location and poststroke depression. The Journal of Neuropsychiatry and Clinical Neurosciences. 1996;8(4):399–403. doi: 10.1176/jnp.8.4.399. [DOI] [PubMed] [Google Scholar]
  77. Murakami T, Hama S, Yamashita H, Onoda K, Kobayashi M, Kanazawa J, et al. Neuroanatomic pathways associated with poststroke affective and apathetic depression. The American Journal of Geriatric Psychiatry. 2013;21(9):840–847. doi: 10.1016/j.jagp.2013.01.057. [DOI] [PubMed] [Google Scholar]
  78. Nishiyama Y, Komaba Y, Ueda M, Nagayama H, Amemiya S, Katayama Y. Early depressive symptoms after ischemic stroke are associated with a left lenticulocapsular area lesion. Journal of Stroke and Cerebrovascular Diseases. 2010;19(3):184–189. doi: 10.1016/j.jstrokecerebrovasdis.2009.04.002. [DOI] [PubMed] [Google Scholar]
  79. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Kappelle LJ. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. Journal of the Neurological Sciences. 2005;228(1):27–33. doi: 10.1016/j.jns.2004.09.031. [DOI] [PubMed] [Google Scholar]
  80. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten ECW, van der Flier WM, Petrovic K, et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. The American Journal of Geriatric Psychiatry. 2006;14(10):834–841. doi: 10.1097/01.JGP.0000214558.63358.94. [DOI] [PubMed] [Google Scholar]
  81. Ojagbemi A, Owolabi M, Atalabi M, Baiyewu O. Stroke lesions and post-stroke depression among survivors in Ibadan, Nigeria. African Journal of Medicine & Medical Sciences. 2013;42(3):245–251. [PubMed] [Google Scholar]
  82. Okada K, Kobayashi S, Yamagata S, Takahashi K, Yamaguchi S. Poststroke apathy and regional cerebral blood flow. Stroke. 1997;28(12):2437–2441. doi: 10.1161/01.str.28.12.2437. [DOI] [PubMed] [Google Scholar]
  83. Oladiji JO, Akinbo SRA, Aina OF, Aiyejusunle CB. Risk factors of post-stroke depression among stroke survivors in Lagos, Nigeria. African Journal of Psychiatry (South Africa) 2009;12(1):47–51. doi: 10.4314/ajpsy.v12i1.30278. [DOI] [PubMed] [Google Scholar]
  84. Onoda K, Kuroda Y, Yamamoto Y, Abe S, Oguro H, Nagai A, et al. Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study. Cerebrovascular Diseases. 2011;31(1):6–11. doi: 10.1159/000319771. [DOI] [PubMed] [Google Scholar]
  85. Paradiso S, Robinson RG. Minor depression after stroke: an initial validation of the DSM-IV construct. American Journal of Geriatric Psychiatry. 1999;7(3):244–251. doi: 10.1097/00019442-199908000-00009. [DOI] [PubMed] [Google Scholar]
  86. Paradiso S, Ostedgaard K, Vaidya J, Ponto LB, Robinson R. Emotional blunting following left basal ganglia stroke: the role of depression and fronto-limbic functional alterations. Psychiatry Research: Neuroimaging. 2013;211(2):148–159. doi: 10.1016/j.pscychresns.2012.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Parikh RM, Lipsey JR, Robinson RG, Price TR. A two year longitudinal study of poststroke mood disorders: prognostic factors related to one and two year outcome. International Journal of Psychiatry in Medicine. 1988;18(1):45–56. doi: 10.2190/lw46-3e9f-kyjm-wxgq. [DOI] [PubMed] [Google Scholar]
  88. Pavlovic AM, Pekmezovic T, Zidverc Trajkovic J, Svabic Medjedovic T, Veselinovic N, Radojicic A, et al. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression. International Journal of Geriatric Psychiatry. 2016;31(1):58–65. doi: 10.1002/gps.4289. [DOI] [PubMed] [Google Scholar]
  89. Pohjasvaara T, Vataja R, Leppävuori A, Kaste M, Erkinjuntti T. Depression is an independent predictor of poor long-term functional outcome post-stroke. European Journal of Neurology. 2001;8(4):315–319. doi: 10.1046/j.1468-1331.2001.00182.x. [DOI] [PubMed] [Google Scholar]
  90. Prasad K, Kaul S, Padma M, Gorthi S, Khurana D, Bakshi A. Stroke management. Annals of Indian Academy of Neurology. 2011;14(5):82–96. doi: 10.4103/0972-2327.83084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Provinciali L, Paolucci S, Torta R, Toso V, Gobbi B, Gandolfo C. Depression after first-ever ischemic stroke: the prognostic role of neuroanatomic subtypes in clinical practice. Cerebrovascular Diseases. 2008;26(6):592–599. doi: 10.1159/000165112. [DOI] [PubMed] [Google Scholar]
  92. Rajashekaran P, Pai K, Thunga R, Unnikrishnan B. Post-stroke depression and lesion location: a hospital based cross-sectional study. Indian Journal of Psychiatry. 2013;55(4):343–348. doi: 10.4103/0019-5545.120546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Ramasubbu, R., & Kennedy, S. H. (1994). Factors complicating the diagnosis of depression in cerebrovascular disease, Part I – Phenomenological and nosological issues. The Canadian Journal of Psychiatry, 39(10), 596–600. [DOI] [PubMed]
  94. Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls. Journal of Affective Disorders. 1999;52(1–3):121–133. doi: 10.1016/s0165-0327(98)00050-0. [DOI] [PubMed] [Google Scholar]
  95. Rashid N, Clarke C, Rogish M. Post-stroke depression and expressed emotion. Brain Injury. 2013;27(2):223–238. doi: 10.3109/02699052.2012.729287. [DOI] [PubMed] [Google Scholar]
  96. Robinson RG, Starkstein SE. Mood disorders following stroke: new findings and future directions. Journal of Geriatric Psychiatry. 1989;22(1):1–15. [PubMed] [Google Scholar]
  97. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients. Importance of location of lesion. Brain. 1984;107(Pt 1):81–93. doi: 10.1093/brain/107.1.81. [DOI] [PubMed] [Google Scholar]
  98. Robinson RG, Lipsey JR, Bolla-Wilson K, Bolduc PL, Pearlson GD, Rao K, et al. Mood disorders in left-handed stroke patients. American Journal of Psychiatry. 1985;142(12):1424–1429. doi: 10.1176/ajp.142.12.1424. [DOI] [PubMed] [Google Scholar]
  99. Rochat L, Van der Linden M, Renaud O, Epiney J-B, Michel P, Sztajzel R, et al. Poor reward sensitivity and apathy after stroke Implication of basal ganglia. Neurology. 2013;81(19):1674–1680. doi: 10.1212/01.wnl.0000435290.49598.1d. [DOI] [PubMed] [Google Scholar]
  100. Sachdev PS, Chen X, Joscelyne A, Wen W, Brodaty H. Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: The Sydney Stroke Study. The American Journal of Geriatric Psychiatry. 2007;15(6):487–496. doi: 10.1097/JGP.0b013e3180581fe6. [DOI] [PubMed] [Google Scholar]
  101. Santa N, Sugimori H, Kusuda K, Yamashita Y, Ibayashi S, Iida M. Apathy and functional recovery following first-ever stroke. International Journal of Rehabilitation Research. 2008;31(4):321–326. doi: 10.1097/MRR.0b013e3282fc0f0e. [DOI] [PubMed] [Google Scholar]
  102. Saxena A, Suman A. Magnitude and determinants of depression in acute stroke patients admitted in a rural tertiary care hospital. Journal of Neurosciences in Rural Practice. 2015;6(2):202–207. doi: 10.4103/0976-3147.153228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Schwartz JA, Speed NM, Brunberg JA, Brewer TL, Brown M, Greden JF. Depression in stroke rehabilitation. Biological Psychiatry. 1993;33(10):694–699. doi: 10.1016/0006-3223(93)90118-w. [DOI] [PubMed] [Google Scholar]
  104. Sharpe M, Hawton K, House A, Molyneux A, Sandercock P, Bamford J, et al. Mood disorder in long-term survivors of stroke: associations with brain lesion location and volume. Psychological Medicine. 1990;20(4):815–828. doi: 10.1017/s0033291700036503. [DOI] [PubMed] [Google Scholar]
  105. Sharpe M, Hawton K, Seagroatt V, Bamford J, House A, Molyneux A, et al. Depressive disorders in long-term survivors of stroke. Associations with demographic and social factors, functional status, and brain lesion volume. British Journal of Psychiatry. 1994;164(3):380–386. doi: 10.1192/bjp.164.3.380. [DOI] [PubMed] [Google Scholar]
  106. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry. 1998;59(suppl 20):22–33. [PubMed] [Google Scholar]
  107. Shi YZ, Xiang YT, Wu SL, Zhang N, Zhou J, Bai Y, et al. The relationship between frontal lobe lesions, course of post-stroke depression, and 1-year prognosis in patients with first-ever ischemic stroke. PloS One. 2014;9(7):e100456. doi: 10.1371/journal.pone.0100456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biological Psychiatry. 1999;45(2):187–192. doi: 10.1016/s0006-3223(98)00178-4. [DOI] [PubMed] [Google Scholar]
  109. Singh A, Black SE, Herrmann N, Leibovitch FS, Ebert PL, Lawrence J, et al. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke. 2000;31(3):637–644. doi: 10.1161/01.str.31.3.637. [DOI] [PubMed] [Google Scholar]
  110. Spitzer R, Gibbon M, Williams J. Structured clinical interview for axis I DSM-IV disorders (SCID) Washington, DC: American Psychiatric Association; 1995. [Google Scholar]
  111. Starkstein SE, Robinson RG, Price TR. Comparison of patients with and without poststroke major depression matched for size and location of lesion. Archives of General Psychiatry. 1988;45(3):247–252. doi: 10.1001/archpsyc.1988.01800270061007. [DOI] [PubMed] [Google Scholar]
  112. Starkstein SE, Robinson RG, Honig MA, Parikh RM, Joselyn J, Price TR. Mood changes after right-hemisphere lesions. British Journal of Psychiatry. 1989;155:79–85. doi: 10.1192/bjp.155.1.79. [DOI] [PubMed] [Google Scholar]
  113. Starkstein SE, Mayberg HS, Preziosi T, Andrezejewski P, Leiguarda R, Robinson R. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. Journal of Neuropsychiatry & Clinical Neurosciences. 1992;4(2):134–139. doi: 10.1176/jnp.4.2.134. [DOI] [PubMed] [Google Scholar]
  114. Starkstein SE, Fedoroff JP, Price TR, Leiguarda R, Robinson RG. Apathy following cerebrovascular lesions. Stroke. 1993;24(11):1625–1630. doi: 10.1161/01.str.24.11.1625. [DOI] [PubMed] [Google Scholar]
  115. Stern RA, Bachman DL. Depressive symptoms following stroke. American Journal of Psychiatry. 1991;148(3):351–356. doi: 10.1176/ajp.148.3.351. [DOI] [PubMed] [Google Scholar]
  116. Stojanovic Z, Stojanovic SV. Emotional reactions in patients after frontal lobe stroke. Vojnosanitetski Pregled. 2015;72(9):770–778. doi: 10.2298/vsp140506066s. [DOI] [PubMed] [Google Scholar]
  117. Tang WK, Chan SSM, Chiu HFK, Ungvari GS, Wong KS, Kwok TCY, et al. Poststroke depression in chinese patients: frequency, psychosocial, clinical, and radiological determinants. Journal of Geriatric Psychiatry and Neurology. 2005;18(1):45–51. doi: 10.1177/0891988704271764. [DOI] [PubMed] [Google Scholar]
  118. Tang WK, Chen YK, Lu JY, Chu WC, Mok VC, Ungvari GS, et al. White matter hyperintensities in post-stroke depression: a case control study. Journal of Neurology, Neurosurgery & Psychiatry. 2010;81(12):1312–1315. doi: 10.1136/jnnp.2009.203141. [DOI] [PubMed] [Google Scholar]
  119. Tang WK, Chen YK, Lu JY, Chu WC, Mok VC, Ungvari GS, et al. Cerebral microbleeds and depression in lacunar stroke. Stroke. 2011;42(9):2443–2446. doi: 10.1161/STROKEAHA.111.614586. [DOI] [PubMed] [Google Scholar]
  120. Tang WK, Chen YK, Lu JY, Chu WC, Mok VC, Ungvari GS, et al. Cerebral microbleeds and symptom severity of post-stroke depression: a magnetic resonance imaging study. Journal of Affective Disorders. 2011;129(1–3):354–358. doi: 10.1016/j.jad.2010.08.007. [DOI] [PubMed] [Google Scholar]
  121. Tang WK, Lu JY, Chen YK, Chu WCW, Mok V, Ungvari GS, et al. Association of frontal subcortical circuits infarcts in poststroke depression: a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke. Journal of Geriatric Psychiatry and Neurology. 2011;24(1):44–49. doi: 10.1177/0891988710392375. [DOI] [PubMed] [Google Scholar]
  122. Tang WK, Chen YK, Liang HJ, Chu WC, Mok VC, Ungvari GS, et al. Location of infarcts and apathy in ischemic stroke. Cerebrovascular Diseases. 2013;35(6):566–571. doi: 10.1159/000351152. [DOI] [PubMed] [Google Scholar]
  123. Tang, W. K., Chen, Y. K., Lu, J. Y., Mok, V. C. T., Chu, W. C. W., Ungvari, G. S., et al. (2013b). Frontal lobe atrophy in depression after stroke. Stroke Research and Treatment, 424769. doi: 10.1155/2013/424769. [DOI] [PMC free article] [PubMed]
  124. Tang WK, Chen Y, Liang H, Chu WC, Mok VC, Ungvari GS, et al. Cerebral microbleeds as a predictor of 1-year outcome of poststroke depression. Stroke. 2014;45(1):77–81. doi: 10.1161/STROKEAHA.113.002686. [DOI] [PubMed] [Google Scholar]
  125. Tang WK, Liu XX, Chen YK, Abrigo J, Chu WCW, Mok VCT, et al. Pontine microbleeds and depression in stroke. Journal of Geriatric Psychiatry and Neurology. 2014;27(3):159–164. doi: 10.1177/0891988714522699. [DOI] [PubMed] [Google Scholar]
  126. Tanislav C, Kropp P, Grittner U, Holzhausen M, Fazekas F, Jungehülsing GJ, et al. Clinically relevant depressive symptoms in young stroke patients—Results of the sifap1 study. Neuroepidemiology. 2015;44(1):30–38. doi: 10.1159/000371389. [DOI] [PubMed] [Google Scholar]
  127. Terroni L, Amaro E, Iosifescu DV, Tinone G, Sato JR, Leite CC, et al. Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. World Journal of Biological Psychiatry. 2011;12(7):539–548. doi: 10.3109/15622975.2011.562242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Terroni L, Amaro E, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, et al. The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region. Neuropsychiatric Disease and Treatment. 2015;11:233–242. doi: 10.2147/NDT.S73722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Toso V, Gandolfo C, Paolucci S, Provinciali L, Torta R, Grassivaro N, et al. Post-stroke depression: research methodology of a large multicentre observational study (DESTRO) Neurological Sciences. 2004;25(3):138–144. doi: 10.1007/s10072-004-0247-y. [DOI] [PubMed] [Google Scholar]
  130. van Dalen JW, van Charante EPM, Nederkoorn PJ, van Gool WA, Richard E. Poststroke apathy. Stroke. 2013;44(3):851–860. doi: 10.1161/STROKEAHA.112.674614. [DOI] [PubMed] [Google Scholar]
  131. Vataja R, Pohjasvaara T, Leppavuori A, Mantyla R, Aronen HJ, Salonen O, et al. Magnetic resonance imaging correlates of depression after ischemic stroke. Archives of General Psychiatry. 2001;58(10):925–931. doi: 10.1001/archpsyc.58.10.925. [DOI] [PubMed] [Google Scholar]
  132. Vataja R, Pohjasvaara T, Mäntylä R, Ylikoski R, Kalska H, Leskelä M, et al. Depression-executive dysfunction syndrome in stroke patients. The American Journal of Geriatric Psychiatry. 2005;13(2):99–107. doi: 10.1176/appi.ajgp.13.2.99. [DOI] [PubMed] [Google Scholar]
  133. Verdelho A, Henon H, Lebert F, Pasquier F, Leys D. Depressive symptoms after stroke and relationship with dementia: a three-year follow-up study. Neurology. 2004;62(6):905–911. doi: 10.1212/01.wnl.0000115107.66957.8c. [DOI] [PubMed] [Google Scholar]
  134. Wang X, Li Y-H, Li M-H, Lu J, Zhao J-G, Sun X-J, et al. Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. European Archives of Psychiatry and Clinical Neuroscience. 2012;262(1):33–38. doi: 10.1007/s00406-011-0209-3. [DOI] [PubMed] [Google Scholar]
  135. Wei N, Yong W, Li X, Zhou Y, Deng M, Zhu H, et al. Post-stroke depression and lesion location: a systematic review. Journal of Neurology. 2015;262(1):81–90. doi: 10.1007/s00415-014-7534-1. [DOI] [PubMed] [Google Scholar]
  136. Wei C, Zhang F, Chen L, Ma X, Zhang N, Hao J. Factors associated with post-stroke depression and fatigue: lesion location and coping styles. Journal of Neurology. 2016;263(2):269–276. doi: 10.1007/s00415-015-7958-2. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  137. Wells, G., Shea, B., O’connell, D., Peterson, J., Welch, V., Losos, M., et al. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  138. Wichowicz HM, Gasecki D, Landowski J, Nyka WM, Kozera G, Cubala WJ. Regional cerebral blood flow (SPECT) asymmetry as a prognostic factor for post-stroke depression: a preliminary observation. Neurology Psychiatry and Brain Research. 2006;13(4):165–167. [Google Scholar]
  139. Wichowicz HM, Gąsecki D, Lass P, Landowski J, Świerkocka M, Wiśniewski G, et al. Clinical utility of chosen factors in predicting post-stroke depression: a one year follow-up. Psychiatria Polska. 2015;49(4):683–696. doi: 10.12740/PP/38439. [DOI] [PubMed] [Google Scholar]
  140. Williamson J, Nyenhuis D, Stebbins GT, Lamb D, Simkus V, Sripathirathan K, et al. Regional differences in relationships between apparent white matter integrity, cognition and mood in patients with ischemic stroke. Journal of Clinical and Experimental Neuropsychology. 2010;32(7):673–681. doi: 10.1080/13803390903427406. [DOI] [PubMed] [Google Scholar]
  141. Withall A, Brodaty H, Altendorf A, Sachdev PS. A longitudinal study examining the independence of apathy and depression after stroke: The Sydney Stroke Study. International Psychogeriatrics. 2011;23(2):264–273. doi: 10.1017/S1041610209991116. [DOI] [PubMed] [Google Scholar]
  142. Wongwandee M, Tangwongchai S, Phanthumchinda K. Relationship between poststroke depression and ischemic lesion location. Journal of the Medical Association of Thailand. 2012;95(3):330–336. [PubMed] [Google Scholar]
  143. Wu R-H, Li Q, Tan Y, Liu X-Y, Huang J. Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors. Neurological Sciences. 2014;35(10):1553–1559. doi: 10.1007/s10072-014-1794-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Xu QG, Cao H, Song QW, Wu JL. Metabolic changes of prefrontal cerebral lobe, white matter and cerebellum in patients with post-stroke depression: a proton magnetic resonance spectroscopy study. Neural Regeneration Research. 2008;3(2):142–147. [Google Scholar]
  145. Yang S, Hua P, Shang X, Cui Z, Zhong S, Gong G, et al. Deficiency of brain structural sub-network underlying post-ischaemic stroke apathy. European Journal of Neurology. 2015;22(2):341–347. doi: 10.1111/ene.12575. [DOI] [PubMed] [Google Scholar]
  146. Yang S, Hua P, Shang X, Cui Z, Zhong S, Gong G, et al. A significant risk factor for poststroke depression: the depression-related subnetwork. Journal of Psychiatry and Neuroscience. 2015;40(4):259–268. doi: 10.1503/jpn.140086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Yang, S. R., Shang, X. Y., Tao, J., Liu, J. Y., & Hua, P. (2015c). Voxel-based analysis of fractional anisotropy in post-stroke apathy. PloS One, 10(1). doi: 10.1371/journal.pone.0116168. [DOI] [PMC free article] [PubMed]
  148. Yasuno F, Taguchi A, Yamamoto A, Kajimoto K, Kazui H, Sekiyama A, et al. Microstructural abnormalities in white matter and their effect on depressive symptoms after stroke. Psychiatry Research - Neuroimaging. 2014;223(1):9–14. doi: 10.1016/j.pscychresns.2014.04.009. [DOI] [PubMed] [Google Scholar]
  149. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research. 1983;17(1):37–49. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]
  150. Zhang T, Jing X, Zhao X, Wang C, Liu Z, Zhou Y, et al. A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients. Journal of Affective Disorders. 2012;136(1–2):e83–e87. doi: 10.1016/j.jad.2011.06.014. [DOI] [PubMed] [Google Scholar]
  151. Zhang P, Xu Q, Dai J, Wang J, Zhang N, Luo Y. Dysfunction of affective network in post ischemic stroke depression: a resting-state functional magnetic resonance imaging study. BioMed Research International. 2014;2014:846830. doi: 10.1155/2014/846830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Zhang Y, Cheng L, Chen Y, Yang G-Y, Liu J, Zeng L. Clinical predictor and circulating microRNA profile expression in patients with early onset post-stroke depression. Journal of Affective Disorders. 2016;193:51–58. doi: 10.1016/j.jad.2015.12.061. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESM 1 (125.1KB, docx)

(DOCX 125 kb)

ESM 2 (143.5KB, docx)

(DOCX 143 kb)

ESM 3 (147.7KB, docx)

(DOCX 147 kb)

ESM 4 (169.8KB, docx)

(DOCX 169 kb)

ESM 5 (135.7KB, docx)

(DOCX 135 kb)

ESM 6 (347.8KB, docx)

(DOCX 347 kb)

ESM 7 (63.5KB, doc)

(DOC 63 kb)

Articles from Neuropsychology Review are provided here courtesy of Springer

RESOURCES